Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity.

Brambilla C, Laffaire J, Lantuejoul S, Moro-Sibilot D, Mignotte H, Arbib F, Toffart AC, Petel F, Hainaut P, Rousseaux S, Khochbin S, de Reyniès A, Brambilla E.

Clin Cancer Res. 2014 Nov 15;20(22):5777-86. doi: 10.1158/1078-0432.CCR-14-0459. Epub 2014 Sep 4.

2.

Shared decision-making in medical encounters regarding breast cancer treatment: the contribution of methodological triangulation.

Durif-Bruckert C, Roux P, Morelle M, Mignotte H, Faure C, Moumjid-Ferdjaoui N.

Eur J Cancer Care (Engl). 2015 Jul;24(4):461-72. doi: 10.1111/ecc.12214. Epub 2014 Jul 18.

PMID:
25040308
3.

Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.

Cutuli B, Lemanski C, Le Blanc-Onfroy M, de Lafontan B, Cohen-Solal-Le-Nir C, Fondrinier E, Mignotte H, Giard S, Charra-Brunaud C, Auvray H, Gonzague-Casabianca L, Quétin P, Fay R.

Cancer Radiother. 2013 Jun;17(3):196-201. doi: 10.1016/j.canrad.2013.01.011. Epub 2013 Mar 26.

PMID:
23538041
4.

[Regional recurrence of triple-negative breast cancer: interest of systematic adjuvant lymph node irradiation?].

Clerc J, Sunyach MP, Duruisseaux M, Mignotte H, Bajard A, Tredan O, Arnaud A.

Gynecol Obstet Fertil. 2013 Feb;41(2):90-5. doi: 10.1016/j.gyobfe.2012.05.002. Epub 2012 Jul 4. French.

PMID:
22771170
5.

Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization.

Castel P, Tassy L, Lurkin A, Blay JY, Meeus P, Mignotte H, Faure C, Ranchere-Vince D, Bachelot T, Guastalla JP, Sunyach MP, Guerin N, Treilleux I, Marec-Berard P, Thiesse P, Ray-Coquard I.

Bull Cancer. 2012 Apr 1;99(4):E34-42. doi: 10.1684/bdc.2012.1559.

6.

[Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node].

Schmitt C, Bouteille C, Faure C, Mignotte H, Tredan O, Bachelot T, Guastalla JP, Arnaud A, Treilleux I, Carrabin N.

Bull Cancer. 2012 Apr 1;99(4):463-9. doi: 10.1684/bdc.2011.1527. French.

7.

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

Houvenaeghel G, Bannier M, Nos C, Giard S, Mignotte H, Jacquemier J, Martino M, Esterni B, Belichard C, Classe JM, Tunon de Lara C, Cohen M, Payan R, Blanchot J, Rouanet P, Penault-Llorca F, Bonnier P, Fournet S, Agostini A, Marchal F, Garbay JR.

Breast. 2012 Apr;21(2):204-9. doi: 10.1016/j.breast.2011.09.013. Epub 2011 Oct 19.

8.

Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'.

Classe JM, Baffert S, Sigal-Zafrani B, Fall M, Rousseau C, Alran S, Rouanet P, Belichard C, Mignotte H, Ferron G, Marchal F, Giard S, Tunon de Lara C, Le Bouedec G, Cuisenier J, Werner R, Raoust I, Rodier JF, Laki F, Colombo PE, Lasry S, Faure C, Charitansky H, Olivier JB, Chauvet MP, Bussières E, Gimbergues P, Flipo B, Houvenaeghel G, Dravet F, Livartowski A.

Ann Oncol. 2012 May;23(5):1170-7. doi: 10.1093/annonc/mdr355. Epub 2011 Sep 6.

9.

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

Cassier PA, Treilleux I, Bachelot T, Ray-Coquard I, Bendriss-Vermare N, Ménétrier-Caux C, Trédan O, Goddard-Léon S, Pin JJ, Mignotte H, Bathélémy-Dubois C, Caux C, Lebecque S, Blay JY.

BMC Cancer. 2011 May 30;11:213. doi: 10.1186/1471-2407-11-213.

10.

Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.

Tunon-de-Lara C, Lemanski C, Cohen-Solal-Le-Nir C, de Lafontan B, Charra-Brunaud C, Gonzague-Casabianca L, Mignotte H, Fondrinier E, Giard S, Quetin P, Auvray H, Cutuli B.

Eur J Surg Oncol. 2010 Dec;36(12):1165-71. doi: 10.1016/j.ejso.2010.09.001.

PMID:
20889280
11.

Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).

Giard S, Chauvet MP, Penel N, Mignotte H, Martel P, Tunon de Lara C, Gimbergues P, Dessogne P, Classe JM, Fondrinier E, Marmousez T.

Ann Oncol. 2010 Aug;21(8):1630-5. doi: 10.1093/annonc/mdp586. Epub 2010 Jan 20.

PMID:
20089557
12.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y.

Crit Rev Oncol Hematol. 2010 Mar;73(3):246-54. doi: 10.1016/j.critrevonc.2009.04.002. Epub 2009 May 12.

PMID:
19442535
13.

Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study.

Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J, Sagan C, Dupre PF, Body G, Giard S.

J Clin Oncol. 2009 Feb 10;27(5):726-32. doi: 10.1200/JCO.2008.18.3228. Epub 2008 Dec 29.

PMID:
19114697
14.

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.

Houvenaeghel G, Nos C, Giard S, Mignotte H, Esterni B, Jacquemier J, Buttarelli M, Classe JM, Cohen M, Rouanet P, Penault Llorca F, Bonnier P, Marchal F, Garbay JR, Fraisse J, Martel P, Fondrinier E, Tunon de Lara C, Rodier JF.

Eur J Surg Oncol. 2009 Jul;35(7):690-5. doi: 10.1016/j.ejso.2008.10.003. Epub 2008 Nov 28.

PMID:
19046847
15.

Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients.

Forgeard C, Benchaib M, Guerin N, Thiesse P, Mignotte H, Faure C, Clement-Chassagne C, Treilleux I.

Am J Surg. 2008 Sep;196(3):339-45. doi: 10.1016/j.amjsurg.2007.07.038. Epub 2008 Jun 30.

PMID:
18585676
16.

[Patients' preferences and decision-making: state of the art and applications in cancer].

Moumjid N, Nguyen F, Bremond A, Mignotte H, Faure C, Meunier A, Carrère MO.

Rev Epidemiol Sante Publique. 2008 Jul;56 Suppl 3:S231-8. doi: 10.1016/j.respe.2008.04.008. Epub 2008 Jun 6. French.

PMID:
18538959
17.

[Oncoplastic technics with nipple-areolar complex resection for the treatment of central breast cancers].

Faure C, Escalon J, Brémond A, Mignotte H, Pérol D, Delay E.

Ann Chir Plast Esthet. 2008 Apr;53(2):112-23. doi: 10.1016/j.anplas.2007.11.003. Epub 2008 Mar 26. French.

PMID:
18372086
18.

Shared decision-making in the physician-patient encounter in France: a general overview.

Moumjid N, Brémond A, Mignotte H, Faure C, Meunier A, Carrère MO.

Z Arztl Fortbild Qualitatssich. 2007;101(4):223-8.

PMID:
17601176
19.

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, Mignotte H, Brémond A, Classe JM, Dravet F, Routiot T, de Lara CT, Avril A, Lorimier G, Fondrinier E, Houvenaeghel G, Avigdor S.

J Clin Oncol. 2007 Aug 20;25(24):3664-9. Epub 2007 May 7.

PMID:
17485709
20.

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.

Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C.

Breast Cancer Res Treat. 2007 Jan;101(2):233-45. Epub 2006 Oct 24.

PMID:
17061047
21.

[Neoadjuvant chemotherapy and ovarian cancer].

Ray-Coquard I, Saba C, Bachelot T, Méeus P, Mignotte H, Blondet R, Treilleux I, Peix M, Guastalla JP.

Bull Cancer. 2006 Jul;93(7):669-76. Review. French.

22.

Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.

Houvenaeghel G, Nos C, Mignotte H, Classe JM, Giard S, Rouanet P, Lorca FP, Jacquemier J, Bardou VJ; Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.

J Clin Oncol. 2006 Apr 20;24(12):1814-22. Epub 2006 Mar 27.

PMID:
16567771
23.

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.

Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.

Genes Chromosomes Cancer. 2005 Aug;43(4):404-13.

PMID:
15887246
24.

Cost comparison of two surgical strategies in the treatment of breast cancer: sentinel lymph node biopsy versus axillary lymph node dissection.

Perrier L, Nessah K, Morelle M, Mignotte H, Carrère MO, Brémond A.

Int J Technol Assess Health Care. 2004 Fall;20(4):449-54.

PMID:
15609794
25.

[Ductal carcinoma in situ of the breast. Analysis of 882 cases].

Cutuli B, Fay R, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Servent V, Giard S, Auvray H, Charra-Brunaud C, Gonzague-Casabianca L, Quetin P.

Presse Med. 2004 Jan 31;33(2):83-9. French.

PMID:
15026697
26.

Elaborating patient information with patients themselves: lessons from a cancer treatment focus group.

Moumjid N, Morelle M, Carrère MO, Bachelot T, Mignotte H, Brémond A.

Health Expect. 2003 Jun;6(2):128-39.

27.

Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients.

Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A.

Eur J Surg Oncol. 2002 Sep;28(6):623-6.

PMID:
12359198
28.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Lemanski C, Auvray H, Jacquot S, Charpentier JC.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):868-79.

PMID:
12095552
29.

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

Bonadona V, Saltel P, Desseigne F, Mignotte H, Saurin JC, Wang Q, Sinilnikova O, Giraud S, Freyer G, Plauchu H, Puisieux A, Lasset C.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):97-104.

30.

Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients.

Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Auvray H, Penault-Llorca F, Charpentier JC.

Eur J Cancer. 2001 Dec;37(18):2365-72.

PMID:
11720829
31.

Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.

Cutuli B, Borel C, Dhermain F, Magrini SM, Wasserman TH, Bogart JA, Provencio M, de Lafontan B, de la Rochefordiere A, Cellai E, Graic Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy JM, Mignotte H, Velten M.

Radiother Oncol. 2001 Jun;59(3):247-55.

PMID:
11369065
32.

Sleep apnoea and Turner's syndrome.

Orliaguet O, Pépin JL, Bettega G, Ferretti G, Mignotte HN, Lévy P.

Eur Respir J. 2001 Jan;17(1):153-5.

33.

Shared decision-making in question.

Charavel M, Bremond A, Moumjid-Ferdjaoui N, Mignotte H, Carrere MO.

Psychooncology. 2001 Mar-Apr;10(2):93-102. Review.

PMID:
11268136
34.

[Serum markers in breast cancer and colorectal cancer (1997)].

Bellet D, Mlika-Cabanne N, Bedenne L, Brun B, Demeaux JL, Legrand JL, Lorimier G, Mignotte H, Ollivier JM, Piperno-Neumann S, Rinaldi Y, Rousset H, Rymer JC, Laversin S.

Gynecol Obstet Fertil. 2001 Jan;29(1):62-3. French. No abstract available.

PMID:
11217195
35.

Tamoxifen and risk of endometrial cancer.

Lasset C, Bonadona V, Mignotte H, Brémond A.

Lancet. 2001 Jan 6;357(9249):66-7. No abstract available.

PMID:
11197379
36.

Lymphatic mapping and sentinel node biopsy of operable breast cancer.

Rodier JF, Routiot T, Mignotte H, Janser JC, Bremond A, David E, Barlier C, Ghnassia JP, Treilleux I, Chassagne C, Velten M.

World J Surg. 2000 Oct;24(10):1220-5; discussion 1225-6.

PMID:
11071466
37.

[The "Action Woman Health" program in three Lyons suburbs].

Mignotte H, Le Goaziou MF, Nachury LP, Pérol D, Fontaniere B, Fouillat V, Lasset C.

Sante Publique. 2000 May;12 Spec No:45-58. French.

PMID:
10989628
38.

[Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].

Mignotte H, Treilleux I, Chassagne-Clément C, Bem C, Lopez R, Martin X, Brémond A.

Bull Cancer. 2000 Jul;87(7-8):600-3. French.

39.

Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.

Treilleux T, Mignotte H, Clement-Chassagne C, Guastalla P, Bailly C.

Eur J Surg Oncol. 1999 Oct;25(5):477-82. Review.

PMID:
10527595
40.

[Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].

Mignotte H, Perol D, Fontanière B, Nachury LP, Blanc-Jouvand A, Fouillat V, Chauvin F, Lasset C.

Bull Cancer. 1999 Jun;86(6):573-9. French.

41.

Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.

Marchal C, Weber B, de Lafontan B, Resbeut M, Mignotte H, du Chatelard PP, Cutuli B, Reme-Saumon M, Broussier-Leroux A, Chaplain G, Lesaunier F, Dilhuydy JM, Lagrange JL.

Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):113-9. Review.

PMID:
10219803
42.

Risk of endometrial cancer in premenopausal women on tamoxifen.

Lasset C, Bonadona V, Chauvin F, Mignotte H, Brémond A.

Lancet. 1998 Oct 31;352(9138):1476. No abstract available.

PMID:
9808024
43.

[The role of the medical corps in a mass screening program for cervical cancer. The program "Female Health Action in 3 urban districts of Lyons].

Mignotte H, Perol D, Fontanière B, Nachury LP, Lasset C.

J Gynecol Obstet Biol Reprod (Paris). 1998 Sep;27(5):501-7. French.

44.

[Identification of axillary sentinel node by lymphotropic dye in breast cancer. Feasibility study apropos of 128 cases].

Rodier JF, Routiot T, Mignotte H, Janser JC, Bremond A, Barlier C, Ghnassia JP, Treilleux I, Chassagne C, Velten M.

Chirurgie. 1998 Jun;123(3):239-46. French.

PMID:
9752514
45.

Prognosis of tamoxifen-associated endometrial cancer.

Lasset C, Mignotte H, Bonadona V, Chauvin F.

J Clin Oncol. 1998 Jul;16(7):2573. No abstract available.

PMID:
9667283
46.

Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients.

Cutuli B, Dhermain F, Borel C, de Larochefordiere A, Graic Y, de Lafontan B, Dilhyudy JM, Mignotte H, Tessier E, Tortochaux J, N'Guyen T, Bey P, Le Mevel-Le Pourhiet A, Velten M, Arriagada R.

Eur J Cancer. 1997 Dec;33(14):2315-20.

PMID:
9616274
47.

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F.

Int J Cancer. 1998 May 4;76(3):325-30.

48.

Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.

Falette N, Paperin MP, Treilleux I, Gratadour AC, Peloux N, Mignotte H, Tooke N, Löfman E, Inganäs M, Bremond A, Ozturk M, Puisieux A.

Cancer Res. 1998 Apr 1;58(7):1451-5.

49.

[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].

Cutuli B, de La Rochefordière A, Dhermain F, Borel C, Graic Y, de Lafontan B, Dilhyudy JM, Mignotte H, Tessier E, Tortochaux J, N'Guyen T, Bey P, Le Mevel-Le Pourhier A, Arriagada R.

Cancer Radiother. 1997;1(4):300-6. Review. French.

PMID:
9435820
50.

[The unknown of tamoxifen].

Mignotte H.

Bull Cancer. 1995 Jan;82(1):6-7. French. No abstract available.

PMID:
7742618

Supplemental Content

Loading ...
Support Center